Not Tagged
Not Tagged
['dlbcl', 'hodgkin', 'cll', 'lymsm']
impressive and so far durable responses to avo in newly-diagnosed cll: at median followup of 35 months, 92.6% of patients are progression-free and alive #ash22 #lymsm 
haematology registrar | fellow @PORTAL_research @harvardmed |
evidence-based medicine | health policy | lymphoma | myeloma |
Fulbright scholar | muso | writer